President Donald Trump has signed an executive order imposing tariffs of up to 100% on imported brandname medicines, unless ...

In Philadelphia this month, Editor in Chief Jonah Comstock spoke with Craig Ackerman, a partner at the Alexander Group, about ...

AZ has yet to file for approval of Imfinzi in the frontline setting for earlier-stage HCC, despite its well-established role ...

Trump started the Section 232 probe into pharma in the spring of 2025, using it as a lever for trade negotiations and MFN ...

The Roivant group company said that treatment with batoclimab had shown some improvement in the eye bulging (proptosis) ...

For Lebrat, it goes back to simplicity of use: the synthetic persona leverages the data a team already has. Synthetic ...

A high burden of infectious diseases coexists with a rapid rise in non-communicable diseases such as diabetes, cancer, and ...

Recordati has received an unsolicited takeover offer from private equity group CVC Capital Partners that, if completed, would ...

Each year, World Bipolar Day is an opportunity to raise awareness and deepen understanding of bipolar disorder, a condition ...

The FDA has approved orforglipron, under the Foundayo trade name, in just 50 days, thanks to a fast track review under the ...

Three behavioural phenomena are particularly consequential in screening and prevention research: ...

Patients in the EU with rare disease thymidine kinase 2 deficiency (TK2d) have their first approved therapy, UCB's Kygevvi, ...